U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 201993

Expand all

RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)
EQ 5MG BASE
Marketing Status: Prescription
Active Ingredient: RIZATRIPTAN BENZOATE
Proprietary Name: RIZATRIPTAN BENZOATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A201993
Product Number: 001
Approval Date: Dec 31, 2012
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)
EQ 10MG BASE
Marketing Status: Prescription
Active Ingredient: RIZATRIPTAN BENZOATE
Proprietary Name: RIZATRIPTAN BENZOATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A201993
Product Number: 002
Approval Date: Dec 31, 2012
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top